Cavernous angioma other diagnostic studies

	Cavernous angioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Cavernous angioma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
CT
MRI
MRA
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cavernous angioma other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cavernous angioma other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cavernous angioma other diagnostic studies
CDC on Cavernous angioma other diagnostic studies
Cavernous angioma other diagnostic studies in the news
Blogs on Cavernous angioma other diagnostic studies
Directions to Hospitals Treating Cavernous angioma
Risk calculators and risk factors for Cavernous angioma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Diagnostic biomarkers can be utilized too in conjunction with imaging tools to identify cavernous angioma.

Diagnostic biomarkers can be utilized too in conjunction with imaging tools to identify cavernous angioma.^[1]

↑ Sone JY, Li Y, Hobson N, Romanos SG, Srinath A, Lyne SB; et al. (2021). "Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage". J Cereb Blood Flow Metab. 41 (11): 2944–2956. doi:10.1177/0271678X211020587. PMC 8756480 Check |pmc= value (help). PMID 34039038 Check |pmid= value (help).